Skip to main content
. 2021 May;79(5):621–632. doi: 10.1016/j.eururo.2021.01.032

Fig. 2.

Fig. 2

HRQOL using the EORTC QLQ-C30 questionnaire. Mean (±95% CIs) scores (0–100) for each scale, adjusted for age and sex, are shown for the whole population and presented by (A) each treatment and (B) tumour stage (using cancer registration data). Mean scores, stratified by age and number of long-term conditions (LTCs), in participants who received (C and D) TURBT for NMIBC (including those who also received additional treatments, (E and F) radical cystectomy (including those who also received additional treatments), and (G and H) radical radiotherapy for MIBC (including those who also received additional treatments). Error bars indicate 95% confidence intervals.

CI = confidence interval; Cyst = cystectomy; HRQOL = health-related quality of life; MIBC = muscle-invasive bladder cancer; NMIBC = non–muscle-invasive bladder cancer; Rad = radical; RT = radiotherapy; TURBT = transurethral resection of bladder tumour.